Page last updated: 2024-10-22

amiodarone and Ovarian Neoplasms

amiodarone has been researched along with Ovarian Neoplasms in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belur Nagaraj, A1
Joseph, P1
Kovalenko, O1
Wang, Q1
Xu, R1
DiFeo, A1

Other Studies

1 other study available for amiodarone and Ovarian Neoplasms

ArticleYear
Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.
    Gynecologic oncology, 2018, Volume: 151, Issue:3

    Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Female; Humans; Neoplastic Stem Cells; Ovarian Neop

2018